Showing results (291-300 of 357) with videos related to
Sort By:
Pageof 36
The Journal of Clinical Investigation|July 18, 2017
Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latencyNancie M Archin, Jennifer L Kirchherr, Julia Am Sung, et al.Lancet (London, England)|August 16, 2005
Depletion of latent HIV-1 infection in vivo: a proof-of-concept studyGinger Lehrman, Ian B Hogue, Sarah Palmer, et al.AIDS Research and Human Retroviruses|July 31, 2012
Acute HIV-1 infection in the Southeastern United States: a cohort studyMehri S McKellar, Anna B Cope, Cynthia L Gay, et al.Plos Pathogens|August 20, 2025
Persistent type I interferon signaling within the brain of people with HIV on ART with cognitive impairmentYuyang Tang, Ling Xie, Ciniso Sylvester Shabangu, et al.Science Advances|April 10, 2026
Histone decrotonylation plays a distinct role in HIV latencyXiaoyi Li, Dajiang Li, Yuyang Tang, et al.Journal of Virology|March 11, 2025
BET degraders reveal BRD4 disruption of 7SK and P-TEFb is critical for effective reactivation of latent HIV in CD4+ T-cellsAnne-Marie W Turner, Frances M Bashore, Shane D Falcinelli, et al.AIDS (London, England)|September 24, 2016
Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durabilityCynthia L Gay, Sarah J Willis, Anna B Cope, et al.Plos Pathogens|June 7, 2024
The histone methyltransferase SETD2 regulates HIV expression and latencyCameron R Bussey-Sutton, Airlie Ward, Joshua A Fox, et al.Nature Immunology|March 26, 2021
Multi-omics analyses reveal that HIV-1 alters CD4+ T cell immunometabolism to fuel virus replicationHaitao Guo, Qi Wang, Khader Ghneim, et al.Cell Reports|February 2, 2017
Benzotriazoles Reactivate Latent HIV-1 through Inactivation of STAT5 SUMOylationAlberto Bosque, Kyle A Nilson, Amanda B Macedo, et al.Pageof 36